Live Breaking News & Updates on Judith shizuru

JSPR Stock Price | Jasper Therapeutics Inc. Stock Quote (U.S.: Nasdaq)

JSPR | Complete Jasper Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Susan-prohaska , Judith-shizuru , Jasper-therapeutics-inc , Jasper-therapeutics , Redwood-city , Jspr , Spr-analyst-estimates , Spr-earnings-estimates , Spr-share-estimates , Spr-analyst-recommendations , Spr-ratings , Asper-therapeutics-inc-analyst-estimates

Jasper Therapeutics : 2022 KOL Day | MarketScreener

Transforming the Field of Hematopoietic Stem Cell Therapies

Nasdaq: JSPR April 28th, 2022

Safe Harbor

Forward-Looking. | April 28, 2022

David-sallman , Judith-shizuru , Lori-muffly , Ron-martell , Jasper-co , Company-annual-reports-on-form , Jasper-therapeutics-inc , Research-translational-medicine , Moffitt-cancer-center , Stanford-university , Nasdaq , Hematopoietic-stem

Jasper Therapeutics Announces Management Changes to Strengthen Leadership Team

REDWOOD CITY, Calif., March 21, 2022 Jasper Therapeutics, Inc. , a biotechnology company focused on hematopoietic cell transplant therapies, today announced changes to its management team,. | March 21, 2022

United-states , John-mullaly , Ronald-martell , Kevin-heller , Judith-shizuru , Strategic-marketing-at-portola-pharmaceuticals , Illinois-institute-of-technology , Jasper-therapeutics-inc , Nasdaq , Product-development , Harvard-university , Stanford-immunology-program